Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tomography, Optical Coherence | 46 | 2022 | 2657 | 7.940 |
Why?
|
Fluorescein Angiography | 30 | 2022 | 940 | 6.910 |
Why?
|
Retinal Vessels | 18 | 2022 | 772 | 5.130 |
Why?
|
Choroid | 8 | 2022 | 322 | 3.530 |
Why?
|
Retinal Diseases | 9 | 2021 | 683 | 2.700 |
Why?
|
Diabetic Retinopathy | 7 | 2021 | 1210 | 2.630 |
Why?
|
Visual Acuity | 21 | 2022 | 2530 | 2.110 |
Why?
|
Retinal Telangiectasis | 3 | 2019 | 24 | 1.900 |
Why?
|
Optic Disk | 7 | 2020 | 400 | 1.890 |
Why?
|
Macular Degeneration | 12 | 2021 | 980 | 1.810 |
Why?
|
Vitrectomy | 4 | 2021 | 365 | 1.620 |
Why?
|
Choroid Diseases | 4 | 2022 | 66 | 1.590 |
Why?
|
Retinal Artery | 4 | 2021 | 111 | 1.580 |
Why?
|
Retinal Vein Occlusion | 4 | 2021 | 137 | 1.560 |
Why?
|
Ciliary Arteries | 3 | 2019 | 17 | 1.450 |
Why?
|
Wet Macular Degeneration | 5 | 2019 | 145 | 1.440 |
Why?
|
Retina | 9 | 2021 | 2616 | 1.390 |
Why?
|
Retinal Detachment | 3 | 2020 | 411 | 1.380 |
Why?
|
Retinal Neovascularization | 3 | 2021 | 244 | 1.320 |
Why?
|
Scleral Buckling | 2 | 2020 | 84 | 1.310 |
Why?
|
Myopia | 2 | 2021 | 254 | 1.290 |
Why?
|
Fundus Oculi | 9 | 2021 | 473 | 1.200 |
Why?
|
Fovea Centralis | 3 | 2022 | 119 | 1.110 |
Why?
|
Retinal Perforations | 3 | 2016 | 131 | 1.070 |
Why?
|
Macular Edema | 2 | 2021 | 359 | 1.030 |
Why?
|
Ophthalmology | 3 | 2021 | 508 | 1.000 |
Why?
|
Vision Disorders | 4 | 2022 | 1058 | 0.980 |
Why?
|
Scotoma | 3 | 2020 | 139 | 0.940 |
Why?
|
Visual Field Tests | 5 | 2019 | 383 | 0.890 |
Why?
|
Macula Lutea | 2 | 2021 | 151 | 0.890 |
Why?
|
Retinal Hemorrhage | 3 | 2021 | 96 | 0.840 |
Why?
|
Central Serous Chorioretinopathy | 1 | 2022 | 27 | 0.820 |
Why?
|
Geographic Atrophy | 2 | 2019 | 66 | 0.780 |
Why?
|
Retinal Vein | 1 | 2021 | 47 | 0.770 |
Why?
|
Vitreous Hemorrhage | 1 | 2021 | 48 | 0.770 |
Why?
|
Artificial Intelligence | 4 | 2021 | 2214 | 0.750 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2020 | 19 | 0.750 |
Why?
|
Optic Neuropathy, Ischemic | 2 | 2018 | 73 | 0.740 |
Why?
|
Visual Fields | 6 | 2019 | 1047 | 0.740 |
Why?
|
Presenilin-1 | 2 | 2021 | 635 | 0.730 |
Why?
|
Microvessels | 5 | 2022 | 544 | 0.710 |
Why?
|
Vitreoretinal Surgery | 1 | 2019 | 27 | 0.700 |
Why?
|
Eye Diseases, Hereditary | 1 | 2020 | 117 | 0.690 |
Why?
|
Retinal Drusen | 3 | 2021 | 66 | 0.670 |
Why?
|
Dark Adaptation | 5 | 2021 | 219 | 0.670 |
Why?
|
Vision, Ocular | 2 | 2022 | 464 | 0.670 |
Why?
|
von Hippel-Lindau Disease | 1 | 2020 | 152 | 0.660 |
Why?
|
Exudates and Transudates | 1 | 2019 | 172 | 0.650 |
Why?
|
Diagnostic Techniques, Ophthalmological | 3 | 2019 | 245 | 0.640 |
Why?
|
Laser Coagulation | 1 | 2020 | 326 | 0.640 |
Why?
|
Polyhydroxyethyl Methacrylate | 1 | 2017 | 31 | 0.630 |
Why?
|
Eye Injuries | 3 | 2016 | 245 | 0.620 |
Why?
|
Giant Cell Arteritis | 2 | 2022 | 292 | 0.610 |
Why?
|
Chorioretinitis | 1 | 2017 | 43 | 0.600 |
Why?
|
Access to Information | 1 | 2020 | 320 | 0.590 |
Why?
|
Retinitis Pigmentosa | 1 | 2020 | 386 | 0.570 |
Why?
|
Optic Atrophy, Hereditary, Leber | 1 | 2016 | 46 | 0.560 |
Why?
|
Blindness | 1 | 2020 | 617 | 0.540 |
Why?
|
Contrast Sensitivity | 3 | 2022 | 244 | 0.530 |
Why?
|
Emulsions | 2 | 2020 | 156 | 0.530 |
Why?
|
Prosthesis Implantation | 3 | 2022 | 642 | 0.500 |
Why?
|
Silicone Oils | 1 | 2014 | 22 | 0.500 |
Why?
|
Angiography | 3 | 2022 | 1639 | 0.500 |
Why?
|
Optic Disk Drusen | 3 | 2021 | 35 | 0.500 |
Why?
|
Endotamponade | 1 | 2014 | 35 | 0.500 |
Why?
|
Cross-Sectional Studies | 19 | 2022 | 25043 | 0.480 |
Why?
|
Prospective Studies | 19 | 2021 | 53288 | 0.480 |
Why?
|
Choroidal Neovascularization | 1 | 2017 | 343 | 0.470 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1525 | 0.460 |
Why?
|
Cataract Extraction | 1 | 2017 | 481 | 0.440 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 5751 | 0.420 |
Why?
|
Humans | 75 | 2022 | 744343 | 0.400 |
Why?
|
Prostheses and Implants | 2 | 2022 | 1387 | 0.390 |
Why?
|
Surgery, Computer-Assisted | 1 | 2019 | 1018 | 0.380 |
Why?
|
Metabolomics | 4 | 2019 | 1484 | 0.340 |
Why?
|
Photography | 3 | 2021 | 520 | 0.340 |
Why?
|
Middle Aged | 33 | 2022 | 213383 | 0.320 |
Why?
|
Pilot Projects | 1 | 2021 | 8324 | 0.320 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39050 | 0.310 |
Why?
|
Female | 38 | 2022 | 380194 | 0.260 |
Why?
|
Male | 38 | 2022 | 350118 | 0.260 |
Why?
|
Postoperative Complications | 2 | 2017 | 15295 | 0.260 |
Why?
|
Aged | 26 | 2021 | 163280 | 0.250 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.250 |
Why?
|
Alzheimer Disease | 2 | 2021 | 8037 | 0.220 |
Why?
|
Aged, 80 and over | 13 | 2020 | 57776 | 0.210 |
Why?
|
Retrospective Studies | 14 | 2022 | 77449 | 0.210 |
Why?
|
Adult | 18 | 2022 | 214055 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
Hypertension | 1 | 2022 | 8480 | 0.210 |
Why?
|
Corneal Diseases | 2 | 2022 | 636 | 0.200 |
Why?
|
Imaging, Three-Dimensional | 4 | 2019 | 4042 | 0.200 |
Why?
|
Intravitreal Injections | 3 | 2019 | 344 | 0.200 |
Why?
|
Glaucoma, Open-Angle | 2 | 2018 | 706 | 0.190 |
Why?
|
Electroretinography | 2 | 2020 | 509 | 0.180 |
Why?
|
Spinocerebellar Ataxias | 1 | 2021 | 91 | 0.180 |
Why?
|
Muscle Spasticity | 1 | 2021 | 154 | 0.180 |
Why?
|
Colombia | 1 | 2021 | 258 | 0.180 |
Why?
|
Vitreoretinopathy, Proliferative | 1 | 2020 | 68 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.180 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2021 | 195 | 0.180 |
Why?
|
Algorithms | 4 | 2021 | 13881 | 0.180 |
Why?
|
Papilledema | 1 | 2021 | 118 | 0.180 |
Why?
|
Intraocular Pressure | 3 | 2021 | 1270 | 0.180 |
Why?
|
Apolipoprotein E3 | 1 | 2019 | 97 | 0.180 |
Why?
|
Glaucoma Drainage Implants | 1 | 2021 | 116 | 0.170 |
Why?
|
Sclera | 1 | 2020 | 200 | 0.170 |
Why?
|
Glaucoma | 2 | 2022 | 1159 | 0.170 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2020 | 194 | 0.170 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2020 | 345 | 0.160 |
Why?
|
Intraoperative Period | 1 | 2019 | 520 | 0.160 |
Why?
|
Nerve Fibers | 2 | 2017 | 687 | 0.150 |
Why?
|
Body Fluids | 1 | 2019 | 319 | 0.150 |
Why?
|
Indocyanine Green | 1 | 2019 | 239 | 0.150 |
Why?
|
Mutation | 2 | 2021 | 29786 | 0.150 |
Why?
|
Capillaries | 2 | 2017 | 773 | 0.140 |
Why?
|
Retinal Pigment Epithelium | 2 | 2018 | 302 | 0.140 |
Why?
|
Vitreous Detachment | 1 | 2016 | 22 | 0.140 |
Why?
|
Fibrinolysin | 1 | 2016 | 131 | 0.140 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2020 | 546 | 0.140 |
Why?
|
Retinal Artery Occlusion | 1 | 2017 | 74 | 0.140 |
Why?
|
Arterioles | 1 | 2017 | 254 | 0.140 |
Why?
|
Coloring Agents | 1 | 2019 | 566 | 0.140 |
Why?
|
Angiogenesis Inhibitors | 2 | 2019 | 2038 | 0.140 |
Why?
|
Dilatation, Pathologic | 1 | 2017 | 520 | 0.140 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 713 | 0.130 |
Why?
|
Early Diagnosis | 1 | 2021 | 1184 | 0.130 |
Why?
|
Retinal Ganglion Cells | 2 | 2017 | 770 | 0.130 |
Why?
|
Case-Control Studies | 4 | 2021 | 21746 | 0.130 |
Why?
|
Lyme Disease | 1 | 2021 | 621 | 0.130 |
Why?
|
Vitreous Body | 1 | 2016 | 389 | 0.120 |
Why?
|
Oxidative Stress | 2 | 2016 | 3086 | 0.120 |
Why?
|
Age of Onset | 1 | 2021 | 3271 | 0.120 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2017 | 349 | 0.120 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12959 | 0.110 |
Why?
|
Granuloma | 1 | 2016 | 319 | 0.110 |
Why?
|
Basketball | 1 | 2013 | 49 | 0.110 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1970 | 0.110 |
Why?
|
Interleukin-8 | 1 | 2015 | 690 | 0.110 |
Why?
|
Incidental Findings | 1 | 2017 | 689 | 0.110 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20822 | 0.100 |
Why?
|
Syndrome | 1 | 2017 | 3251 | 0.100 |
Why?
|
Staphylococcus epidermidis | 1 | 2011 | 117 | 0.100 |
Why?
|
Daptomycin | 1 | 2011 | 73 | 0.100 |
Why?
|
Optic Nerve Diseases | 1 | 2014 | 327 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2020 | 11725 | 0.090 |
Why?
|
Vancomycin Resistance | 1 | 2011 | 128 | 0.090 |
Why?
|
Inflammasomes | 1 | 2015 | 495 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1061 | 0.090 |
Why?
|
Drug Substitution | 1 | 2013 | 281 | 0.090 |
Why?
|
Sarcoidosis | 1 | 2016 | 506 | 0.090 |
Why?
|
DNA, Mitochondrial | 1 | 2015 | 817 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2019 | 3508 | 0.090 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 664 | 0.090 |
Why?
|
Lipids | 2 | 2018 | 3305 | 0.090 |
Why?
|
Blast Injuries | 1 | 2013 | 302 | 0.090 |
Why?
|
Young Adult | 5 | 2022 | 56430 | 0.090 |
Why?
|
Endophthalmitis | 1 | 2011 | 262 | 0.080 |
Why?
|
Massachusetts | 1 | 2021 | 8663 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8642 | 0.080 |
Why?
|
Eye Infections, Bacterial | 1 | 2011 | 235 | 0.080 |
Why?
|
Boston | 1 | 2021 | 9313 | 0.080 |
Why?
|
Prognosis | 2 | 2020 | 29063 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3046 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 2016 | 2158 | 0.070 |
Why?
|
Time Factors | 2 | 2021 | 40075 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10397 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2021 | 63114 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2015 | 3200 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3336 | 0.060 |
Why?
|
Software | 1 | 2019 | 4443 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2291 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15076 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 1 | 2013 | 3772 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2016 | 5097 | 0.060 |
Why?
|
Cognition | 1 | 2021 | 6770 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16365 | 0.060 |
Why?
|
Schizophrenia | 1 | 2022 | 6882 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 12072 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2011 | 1400 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4687 | 0.050 |
Why?
|
Portugal | 1 | 2020 | 87 | 0.050 |
Why?
|
MicroRNAs | 1 | 2016 | 3752 | 0.050 |
Why?
|
Rabbits | 2 | 2020 | 4894 | 0.050 |
Why?
|
Apolipoprotein E2 | 1 | 2019 | 127 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.040 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2020 | 226 | 0.040 |
Why?
|
Densitometry | 1 | 2018 | 156 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2019 | 3760 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 1654 | 0.040 |
Why?
|
Tonometry, Ocular | 1 | 2018 | 237 | 0.040 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.040 |
Why?
|
Ophthalmoscopy | 1 | 2017 | 176 | 0.040 |
Why?
|
Bruch Membrane | 1 | 2016 | 64 | 0.040 |
Why?
|
Sensory Thresholds | 1 | 2017 | 391 | 0.030 |
Why?
|
Tissue Adhesions | 1 | 2016 | 235 | 0.030 |
Why?
|
Vision, Low | 1 | 2017 | 168 | 0.030 |
Why?
|
Homozygote | 1 | 2019 | 1785 | 0.030 |
Why?
|
Amyloid | 1 | 2019 | 795 | 0.030 |
Why?
|
Aneurysm | 1 | 2018 | 339 | 0.030 |
Why?
|
Cornea | 1 | 2022 | 1524 | 0.030 |
Why?
|
Motor Skills | 1 | 2017 | 522 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 597 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7181 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 780 | 0.030 |
Why?
|
Explosions | 1 | 2013 | 109 | 0.030 |
Why?
|
Energy Intake | 1 | 2020 | 2148 | 0.030 |
Why?
|
Dietary Fats | 1 | 2020 | 2017 | 0.030 |
Why?
|
Pedigree | 1 | 2019 | 4644 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2016 | 1213 | 0.020 |
Why?
|
Chronic Disease | 2 | 2018 | 9146 | 0.020 |
Why?
|
Adolescent | 2 | 2015 | 85781 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2203 | 0.020 |
Why?
|
Antioxidants | 1 | 2016 | 1663 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2020 | 18029 | 0.020 |
Why?
|
Child | 1 | 2015 | 77709 | 0.020 |
Why?
|
Life Style | 1 | 2018 | 3835 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2759 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6459 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5882 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2018 | 3966 | 0.020 |
Why?
|
Cataract | 1 | 2011 | 834 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13989 | 0.020 |
Why?
|
Cohort Studies | 2 | 2017 | 40561 | 0.020 |
Why?
|
Comorbidity | 1 | 2018 | 10388 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13408 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6489 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2015 | 5021 | 0.010 |
Why?
|
Diet | 1 | 2020 | 7939 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8340 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15997 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 12720 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15540 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10943 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.010 |
Why?
|
Internship and Residency | 1 | 2017 | 5788 | 0.010 |
Why?
|
Animals | 2 | 2020 | 168757 | 0.010 |
Why?
|
Brain | 1 | 2019 | 26385 | 0.010 |
Why?
|
United States | 1 | 2020 | 69872 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 35421 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 72290 | 0.010 |
Why?
|